Tianjin Pharmacn Medical Technology Co., Ltd is a high-tech enterprise that integrates the research and development, manufacturing, and marketing of active pharmaceutical ingredients (APIs) and intermediates. The company boasts a state-of-the-art R&D centre, optimization workshops, and industrial preparation pilot workshops, with a primary focus on the R&D and production of advanced pharmaceutical raw materials and intermediates, particularly in the fields of anti-tumour, diabetes, and cardiovascular intermediates. Additionally, Tianjin Pharmacn provides a variety of technical services, including impurity tracking, stability analysis, and CTD documentation. Equipped with over 100 reactors ranging from 100L to 5000L, the company has an impressive annual manufacturing capacity of 500 tons, capable of conducting high and low-temperature reactions from -100 to 240?, various catalytic reactions, as well as anhydrous and anaerobic reactions up to 5MPa. Tianjin Pharmacn is recognised for its leading technical capabilities in the synthesis of heterocyclic compounds and is supported by an experienced quality management team that has established a comprehensive quality standard system ensuring rigorous oversight and management throughout the entire product lifecycle.

Services include:
- Regulatory Services
- Containment
- APIs (Active Pharmaceutical Ingredients)
- Contract Development and Manufacturing (CDMO)
- Intermediates
- Fine Chemicals
- Laboratory and Analytical Services

In summary, Tianjin Pharmacn Medical Technology Co., Ltd stands out as a reliable supplier to the pharmaceutical industry, combining advanced technology with a commitment to quality. For further information, please visit pharmacn.com.